These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9503169)

  • 1. Fibrinogen and coronary heart disease--what does it mean?
    Oliver MF
    Eur Heart J; 1998 Jan; 19(1):8-9. PubMed ID: 9503169
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.
    Yarnell J; McCrum E; Rumley A; Patterson C; Salomaa V; Lowe G; Evans A
    Eur Heart J; 2005 Feb; 26(4):332-42; discussion 317-8. PubMed ID: 15618045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of hemostatic markers in the pathogenesis of coronary diseases].
    Russo C
    Recenti Prog Med; 2002 Feb; 93(2):75-7. PubMed ID: 11887348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis.
    Coutinho Tde A; Turner ST; Peyser PA; Bielak LF; Sheedy PF; Kullo IJ
    Am J Hypertens; 2007 Jan; 20(1):83-9. PubMed ID: 17198917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Juhan-Vague I; Ferrieres J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetiere P;
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1255-61. PubMed ID: 12775578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel risk factors and markers for coronary disease.
    Ridker PM
    Adv Intern Med; 2000; 45():391-418. PubMed ID: 10635056
    [No Abstract]   [Full Text] [Related]  

  • 8. Why fibrinogen should be measured as part of the coronary heart disease risk profile.
    Vorster HH; Venter CS
    S Afr Med J; 1993 May; 83(5):309-10. PubMed ID: 8211418
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrinogen as a cardiovascular risk factor--marker or causal factor?].
    Halvorsen S
    Tidsskr Nor Laegeforen; 1999 Aug; 119(19):2829-32. PubMed ID: 10494205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombogenesis in atherosclerosis of the coronary arteries].
    Petrova TP; Pavlishchuk SA
    Ter Arkh; 1968 Jan; 40(1):41-5. PubMed ID: 5747054
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
    J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between white blood cell count and several risk factors for coronary heart disease in patients with systemic hypertension.
    Capuano V; Lamaida N; Mazzotta G; Scotto di Quacquaro G
    G Ital Cardiol; 1998 May; 28(5):530-5. PubMed ID: 9646068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of changes in the sterine-fibrinogen complexes in the development of arteriosclerosis].
    Palamarchuk VI
    Vrach Delo; 1981 Jan; (1):87-90. PubMed ID: 7210645
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinogen, social position, and "Mendelian randomisation".
    Jousilahti P; Salomaa V
    J Epidemiol Community Health; 2004 Oct; 58(10):883. PubMed ID: 15365117
    [No Abstract]   [Full Text] [Related]  

  • 16. Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies.
    Smith GD; Harbord R; Milton J; Ebrahim S; Sterne JA
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2228-33. PubMed ID: 16123313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein and vascular disease.
    Magadle R; Weiner P; Sotzkover A; Berar-Yanay N
    Isr Med Assoc J; 2001 Jan; 3(1):50-2. PubMed ID: 11344805
    [No Abstract]   [Full Text] [Related]  

  • 18. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
    Empana JP; Sykes DH; Luc G; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Bingham A; Montaye M; Ruidavets JB; Haas B; Evans A; Jouven X; Ducimetiere P;
    Circulation; 2005 May; 111(18):2299-305. PubMed ID: 15867179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In search of the grail: the never-ending story of biomarkers for coronary risk prediction.
    Sans S
    Eur Heart J; 2004 Aug; 25(15):1271-3. PubMed ID: 15288150
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of inflammation for heart disease risk cannot be determined by correlations between C-reactive protein and risk factors.
    Engström G
    Arch Intern Med; 2006 May; 166(9):1040; author reply 1040-1. PubMed ID: 16682580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.